HBI
58
3
HUM
41
-4
IFF
47
-4
KIM
72
2
DG
8
-2
CMA
61
-3
SYF
86
-6
PG
50
2
JWN
48
-2
SHW
62
-6
TJX
62
-2
SLG
57
-3
ILMN
32
-9
RSG
65
-3
ESS
62
-3
RHI
57
-6
M
31
-3
THC
60
-5
C
62
4
IPG
34
-9
HBI
58
3
HUM
41
-4
IFF
47
-4
KIM
72
2
DG
8
-2
CMA
61
-3
SYF
86
-6
PG
50
2
JWN
48
-2
SHW
62
-6
TJX
62
-2
SLG
57
-3
ILMN
32
-9
RSG
65
-3
ESS
62
-3
RHI
57
-6
M
31
-3
THC
60
-5
C
62
4
IPG
34
-9
Financhill
Back

Oxford Square Capital Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
28

OXSQ
Oxford Square Capital

Last Price:
2.70
Seasonality Move:
6.23%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
28
Oxford Square Capital (OXSQ) is a Sell

Is Oxford Square Capital a Buy, Sell or Hold?

  • The current Oxford Square Capital [OXSQ] share price is $2.70. The Score for OXSQ is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • OXSQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OXSQ Stock Price Chart

What is Oxford Square Capital's stock price today?

  • The Oxford Square Capital share price today is $2.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OXSQ is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

OXSQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 24.8 Sell
Chaikin Money Flow: -542141 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.83 - 2.95) Sell
Bollinger Bands (100): (2.86 - 3) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

OXSQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.85 Sell
20-day SMA: 2.88 Sell
50-day SMA: 2.87 Sell
200-day SMA: 3.02 Sell
8-day EMA: 2.82 Sell
20-day EMA: 2.86 Sell
50-day EMA: 2.89 Sell
200-day EMA: 2.97 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Oxford Square Capital Earnings Growth & OXSQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.17 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Oxford Square Capital Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):